Furthermore, ALK1 revealed to be a potential marker for disease severity in HHT patients, whereas ALK5 and exosomal particle concentration emerged to be potential markers for epistaxis severity. This evidence concerns the gene TGFBR1 and hereditary hemorrhagic telangiectasia.